Menu

0

ISO 16256:2012

Clinical laboratory testing and in vitro diagnostic test systems — Reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases

Publication date:   Dec 6, 2012

95.99 Withdrawal of Standard   Oct 14, 2021

General information

95.99 Withdrawal of Standard   Oct 14, 2021

ISO

ISO/TC 212 Clinical laboratory testing and in vitro diagnostic test systems

International Standard

11.100.10   In vitro diagnostic test systems

Buying

  Withdrawn

PDF - €76.23

  English   French   Russian  



Buy

Scope

ISO 16256:2012 describes a method for testing the susceptibility to antifungal agents of yeasts, including Candida spp. and Cryptococcus neoformans, that cause infections. The reference method described here has not been used in studies of the yeast forms of dimorphic fungi, such as B. dermatitidis and/or H. capsulatum variety capsulatum.
ISO 16256:2012 describes the broth microdilution reference method which can be implemented by either of two pathways. One pathway involves visual determination of MICs (CLSI method); the second pathway involves spectrophotometric determination of MICs (EUCAST method).

Life cycle

NOW

WITHDRAWN
ISO 16256:2012
95.99 Withdrawal of Standard
Oct 14, 2021

REVISED BY

PUBLISHED
ISO 16256:2021